autologous monocytes
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 20, 2016 (NCT02948426)
Timeline
Indications
Mechanism of action
- MonocytesSupplementation
supplementation - monocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous monocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06707389 | Early Phase 1 (Phase 1) | Jan 1, 2025 | Sun Yat-Sen University |
| NCT05100641 | Phase 3 | Mar 31, 2022 | AiVita Biomedical, Inc. |
| NCT02948426 | Phase 1 | Oct 20, 2016 | National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AiVita Biomedical, Inc. | For profit | 1 | 1 | 1 | 2022 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2016 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1